BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Debt / NOTE 1.250% 5/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
547,434,225
Holdings value
$521,865,010
% of all portfolios
0.001%
Number of holders
58
Number of buys
24
Number of sells
-28
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Period Principal Value Change Price Investors
2025 Q3 547,434,225 $521,865,010 +$30,970,903 $0.95 58
2025 Q2 537,501,514 $507,973,851 +$81,756,015 $0.9413 66
2025 Q1 446,615,880 $421,992,836 -$3,974,640 $0.9439 63
2024 Q4 434,189,749 $403,988,210 +$16,728,324 $0.928 71
2024 Q3 410,986,406 $391,760,463 -$28,564,977 $0.9506 61
2024 Q2 441,880,177 $423,836,043 -$26,274,760 $0.9566 57
2024 Q1 467,435,000 $463,851,707 +$11,259,006 $0.9906 56
2023 Q4 460,780,303 $474,919,727 +$15,228,829 $1.03 56
2023 Q3 446,064,779 $443,342,534 +$475,537 $0.9908 48
2023 Q2 446,081,200 $450,395,136 +$30,175,858 $1.01 48
2023 Q1 416,185,033 $434,808,012 +$21,703,092 $1.04 45
2022 Q4 378,710,174 $408,842,645 -$98,743,328 $1.08 44
2022 Q3 339,484,035 $338,737,224 +$18,727,378 $1 38
2022 Q2 320,189,619 $320,118,053 -$3,637,441 $1 35
2022 Q1 323,841,062 $326,316,486 +$104,678,749 $1 29
2021 Q4 217,348,919 $227,106,951 -$32,276,030 $1.04 32
2021 Q3 246,569,715 $248,479,380 +$2,707,713 $1 26
2021 Q2 243,769,000 $245,269,238 +$245,269,238 $1 28